Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock

Shock

Volumn 10, Issue 6, 1998, Pages 395-400

  Bloom, Ona ^a   Wang, Haichao ^a   Ivanova, Svetlana ^a   Vishnubhakat, Jaideep M ^a   Ombrellino, Michael ^a   Tracey, Kevin J ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL LINE; DISEASE MODEL; DRUG EFFECT; HUMAN; HYPOPHYSECTOMY; MACROPHAGE; METABOLISM; MOUSE; PHYSIOLOGY; RAT; SECRETION; SEPTIC SHOCK;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; HEMOGLOBINS; HUMANS; HYPOPHYSECTOMY; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; RATS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032238463     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199812000-00003     Document Type: Article

References (38)

1. Butler LD, Layman NK, Riedl PE, et al: Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha. J Neuroimmunol 24:143-153, 1989.
2. Zuckerman, SH, Shellhaas J, Butler LD: Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19:301-305, 1989.
3. Silverstein R, Turley BR, Christoffersen CA, Johnson DC, Morrison DC: Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: Evidence of a role for the pituitary. J Exp Med 173:357-365, 1991.
4. Bertini R, Bianchi M, Ghezzi P: Adrenalectomy sensitizes mice to the lethal effects of interleukin-1 and tumor necrosis factor. J Exp Med 167:1708-1712, 1988.
5. Brouckaert P, Everaerdt B, Fiers W: The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor. Eur J Immunol 22:981-986, 1992.
6. Fan J, Gong XQ, Wu J, Zhang YF, Xu RB: Effect of glucocorticoid receptor (GR) blockade on endotoxemia in rats. Circ Shock 42:76-82, 1994.
7. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474, 1986.
8. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662-664, 1987.
9. Villa, P, Meazza C, Sironi M, et al: Inhibition of multiple proinflammatory mediators (TNF, IL-6 and NO) abrogate lethality in a murine model of polymicrobial sepsis. J Endotoxin Res 4:197-204, 1997.
10. Schumann, RR, Leong SR, Flaggs GW, et al: Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431, 1990.
11. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433, 1990.
12. Kaca W, Roth RI, Levin J: Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biology activity. J Biochem 269:25078-25084, 1994.
13. Roth RI, Kaca W, Levin J: Hemoglobin: A newly recognized binding protein for bacterial endotoxins (LPS). Prog Clin Biol Res 388:161-172, 1994.
14. Roth RI: Hemoglobin enhances the binding of bacterial endotoxin to human endothelial cells. Thromb Haemost 76:258-262, 1996.
15. Su D, Roth DL, Yoshida M, Levin J: Hemoglobin increases mortality from bacterial endotoxin. Infect Immun 65:1258-1266, 1997.
16. White CT, Murray AJ, Smith DJ, Greene JR, Bolin RB: Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med 108:132-137, 1986.
17. Zellweger R, Zhu XH, Wichmann HM, Ayala A, DeMaso CM, Chaudry IH: Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 157:5748-5754, 1996.
18. Bernhagen J, Calandra T, Mitchell RA, ET AL: Macrophage migration inhibitory factor (MIF) is a pituitary-derived cytokine and potentiates lethal endotoxaemia. Nature 365:756-769, 1993.
19. Zellweger R, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH: Prolactin: A novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage. J Surg Res 63:53-58, 1996.
20. Edwards CK, Lorence RM, Dunham DM, et al: Hypophysectomy inhibits the synthesis of tumor necrosis factor-alpha by rat macrophages: Partial restoration by exogenous growth hormone or interferon-gamma. Endocrinology 128:989-996, 1991.
21. Martin LW, Lipton JM: Acute phase response to endotoxin: Rise in plasma alpha-MSH and effects of alpha-MSH injection. Am J Physiol Regul Integr Comp Physiol 259:R768-R772, 1990.
22. Flick DA, Gifford GE: Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167-175, 1984.
23. Drabkin DL: Heme binding and transport-a spectrophotometric study of plasma glycoglobulin hemochromogens. Proc Natl Acad Sci USA 68:609-613, 1971.
24. Engstrom, KG, Ohlsson L, Oscarsson J:. Effect of hypophysectomy and growth hormone substitution on red blood cell morphology and filterability in rats. J Lab Clin Med 116:196-205, 1990.
25. Bornside GH, Bouis Jr PJ, Cohn Jr I: Enhancement of Escherichia coli infection and endotoxic activity by hemoglobin and ferric ammonium citrate. Surgery 68:350-355, 1970.
26. Simmons RL, Diggs JW, Sleeman HK: Pathogenesis of peritonitis. 3. Local adjuvant action of hemoglobin in experimental E. coli peritonitis. Surgery 63:810-815, 1968.
27. Van Vunakis H, Ruffilli A, Levine L: Colicine K and endotoxins: Effect of hemoglobin and its subunits on their antibiotic and serological properties. Biochem Biophys Res Commun 16:293-299, 1964.
28. Eaton JW, Brandt P, Mahoney JR, Lee Jr JT: Haptoglobin: A natural bacteriostat. Science 215:691-693, 1982.
29. Feola M, Simoni J, Dobke M, Canizaro PC: Complement activation and the toxicity of stroma-free hemoglobin solutions in primates. Circ Shock 25:275-290, 1988.
30. Feola M, Simoni J, Tran R, Canizaro PC: Mechanisms of toxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 16:217-226, 1988.
31. Yoshida M, Roth RI, Levin J: The effect of cell-free hemoglobin on intravascular clearance and cellular, plasma, and organ distribution of bacterial endotoxin in rabbits. J Lab Clin Med 126:151-160, 1995.
32. Kaca W, Roth RI, Levin J: Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem 269:25078-25084, 1994.
33. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318: 1481-1486, 1988.
34. Rush, B, NL Lee: Clinical presentation of nonhaemolytic transfusion reactions. Anaesth Intensive Care 8:125-131, 1980.
35. Ferrara JL: The febrile platelet transfusion reaction: A cytokine shower Transfusion 35:89-90, 1995.
36. Yoshioka T, Sugimoto T, Ukai T, Oshiro T: Haptoglobin therapy for possible prevention of renal failure following thermal injury: A clinical study. J Trauma 25:281-287, 1985.
37. Vertrees RA, Conti VR, Lick DS, Zwischenberger JB, McDaniel LB, Shulman G: Adverse effects of postoperative infusion of shed mediastinal blood. Ann Thorac Surg 62:717-723, 1996.
38. Rocke DA, Gaffin SL, Wells MT, Koen Y, Brock-Utine JG: Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 93: 832-837, 1987.